Search results

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

ANSTO is one of the world's leading providers of irradiation services for silicon ingots, which are used by the multimillion dollar electronics industry across Europe and Asia. Each year, ANSTO irradiates more than 50 tonnes of silicon.

In Australia and the Southeast Asia basin, the ANSTO facility offers a wide range of unique nuclear-beam techniques for cultural heritage research.

Deuteration and nuclear techniques can contribute to the science of beauty.

ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.

We have provided answers to some the frequently asked questions about the CORIS360® imaging technology.

Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub

ANSTO recognises local Indigenous heritage in new mural

Australia’s new state-of-the-art nuclear medicine facility gets green light.

ABC has reported space research on plants being sent to the moon at the Centre for Accelerator Science.

Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

As a new or returning user, there are certain requirements that must be completed to ensure that your beamtime at the Australian Synchrotron runs smoothly.

Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.